Table 5.
Agents for pharmacological interventions.
| Pharmacologic strategies | Recommendations |
|---|---|
| Testosterone104,105 | In lower doses, testosterone increases protein synthesis |
| Testosterone is the most effective and safest if not at high doses of 300 and 600 mg/week | |
| Selective androgen receptor modulators (SARMs)107 | SARMs appear to be safe and effective in increasing lean body mass |
| Clinical trials of long-term follow-ups are needed to demonstrate long-term safety and efficacy of selective SARMs | |
| GH/IGF-1125 | Side effects such as orthostatic hypotension, gynecomastia, myositis, and edema in single small study |
| Ghrelin and Ghrelin receptor agonist113 | Studies about ghrelin or ghrelin receptor agonists had positive effects on food intake and increased muscle mass and function. |
| Angiotensin-converting enzyme inhibitor105,115 | Perindopril has shown to increase physical performance and to reduce the incidence of hip fractures in the elderly |
Abbreviations: GH, growth hormone; IGF-1 insulin like growth factor-1.